Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART

Haematologica

Volumn 93, Issue 1, 2008, Pages 149-150

  Navarro, José Tomás ^a,b   Vall Llovera, Ferran ^a   Mate, José Luis ^a   Morgades, Mireia ^a   Feliu, Evarist ^a   Ribera, Josep Maria ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

AIDS; Frequency; Lymphoma; Meningeal

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRAIN BIOPSY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; EPSTEIN BARR VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LYMPHOMA; MICROSCOPY; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MENINGES; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 38549094695     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11767     Document Type: Article

References (10)

1. Bower M, Flfe K, Sullivan A, Kirk S, Phillips RH, Nelson M, et al. Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma. Eur J Cancer 1999;35:601-4.
2. Levine AM, Wernz JC, Kaplan L, Rodman N, Cohen P, Metroka C, et al. Low dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. JAMA 1991;266:84-8.
3. Sarker D, Thirlwell C, Nelson M, Gazzard B, Bower M. Leptomeningeal disease in AIDS-related non-Hodgkin's lymphoma. AIDS 2003;17:861-5.
4. Kirk O, Pedersen C, Cozzi-Lepri A, Antunes F, Miller V, Gatell JM, et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001;98:3406-12.
5. Navarro WH, Kaplan LD. AIDS-related lymphoproliferative disease. Blood 2006;107:13-20.
6. Diamond C, Taylor TH, Aboumrad T, Antón-Culver H. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active anti-retroviral therapy. Cancer 2006;106:128-35.
7. Navarro JT, Ribera JM, Oriol A, Vaquero M, Romeu J, Batlle M, et al. Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone. Br J Haematol 2001;112:909-15.
8. Diamond C, Taylor TH, Im T, Miradi M, Wallace M, Anton-Culver H. Highly active antiretroviral therapy is associated with improved survival among patients with AIDS-related primary central nervous system non-Hodgkin's lymphoma. Curr HIV Res 2006;4:375-8.
9. Bower M, Powles T, Nelson M, Mandalia S, Gazzard B, Stebbing J. Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma. J Natl Cancer Inst 2006;98:1088-91.
10. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. CDC. 1993. Morb Mortal Wkly Rep 1992;41:1-20.